Tripartite Avigan Alliance Aims For Global Access

Fujifilm Taps Dr Reddy's, GRA

Fujifilm Toyama seals three-way deal to accelerate the development and global supply of favipiravir, close on the heels of the arrival of a generic version of the antiviral in India under restricted emergency use for the treatment of COVID-19.

Hands_Sun_Puzzle_Pieces
New Global Partnership To Provide Favipiravir Access • Source: Shutterstock

Days after Glenmark Pharmaceuticals Ltd. made headlines with the launch of a generic version of favipiravir in India, the antiviral's originator Fujifilm Toyama Chemical Co. Ltd. has made significant strides to bolster manufacturing and supplies through a wide-ranging deal with front-line Indian firm Dr. Reddy's Laboratories Ltd. and Global Response Aid (GRA), a provider of medical supplies and pharmaceuticals.

The tripartite agreement gives Dr Reddy’s exclusive manufacturing rights to the product, while the Indian firm and GRA have also...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip